SCHEMBL5887589

SCHEMBL5887589

COC1=CC[CH]C(c2ccccc2F)=C1c1ccc(Cl)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APEX1 P27695 1/20 0.36
HSP90AA1 P07900 2/20 0.34
HSP90AB1 P08238 2/20 0.34
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33
NPC1 O15118 1/20 0.32
TP53 P04637 1/20 0.32
MAPT P10636 1/20 0.32
NFKB1 P19838 1/20 0.32
RAB9A P51151 1/20 0.32
NFKB2 Q00653 1/20 0.32
RELA Q04206 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
FFAR2 O15552 2/20 0.31
KDM4E B2RXH2 1/20 0.31
HSD11B1 P28845 2/20 0.31
HTR2C P28335 1/20 0.31
HTR7 P34969 1/20 0.31
CHRM1 P11229 1/20 0.30
PTGS2 P35354 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5887191 0.88 MEN1 (0.37) NPC1TP53MAPTNFKB1RAB9A
SCHEMBL5887625 0.87 HSP90AA1 (0.36) HSP90AA1HSP90AB1SLC6A4SLC6A3NPC1
SCHEMBL5887667 0.86 NPC1 (0.39) HSP90AA1HSP90AB1SLC6A4SLC6A3NPC1
SCHEMBL5887653 0.86 FFAR2 (0.40) HSP90AA1HSP90AB1SLC6A4SLC6A3NPC1
SCHEMBL6416879 0.82 HPGD (0.32) HSP90AA1HSP90AB1TP53
SCHEMBL5887426 0.78 MEN1 (0.34) HSP90AA1HSP90AB1NPC1TP53RAB9A
SCHEMBL5887155 0.76 NOTUM (0.36) SLC6A3NPC1MAPTSMN1; SMN2
SCHEMBL5887347 0.75 MEN1 (0.35) TP53MAPTHTR2C
SCHEMBL5887288 0.74 ALDH1A3 (0.41) SMN1; SMN2KDM4E
SCHEMBL6047606 0.72 NR1I3 (0.39) SLC6A3NPC1TP53MAPTNFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7037931-B2 Corticotropin releasing factor moderator; analgesics; drug abruse, drug dependency; schizophrenia JANSSEN PHARMACEUTICA N.V. (BE) 2006-05-02 US claimed
JP-2006501194-A 2006-01-12 JP claimed
EP-1525190-A1 CCK-1 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-04-27 EP claimed
WO-2004007463-A1 CCK-1 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2004-01-22 WO claimed